Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aldeyra Therapeutics Inc.

    NASDAQ: ALDX · Real-Time Price · USD
    3.88
    0.37 (10.54%)
    At close: Jun 26, 2025, 3:59 PM
    3.88
    0.13%
    Pre-market: Jun 27, 2025, 08:00 AM EDT

    Aldeyra Therapeutics Statistics

    Share Statistics

    Aldeyra Therapeutics has 59.9M shares outstanding. The number of shares has increased by 0.5% in one year.

    Shares Outstanding

    n/a
    		 59.9M

    Shares Change (YoY)

    n/a
    		 0.5%

    Shares Change (QoQ)

    n/a
    		 0.27%

    Owned by Institutions (%)

    n/a
    		 62.48%

    Shares Floating

    n/a
    		 58.15M

    Failed to Deliver (FTD) Shares

    n/a
    		 21

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.71M, so 7.86% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.71M

    Short % of Shares Out

    n/a
    		 7.86%

    Short % of Float

    n/a
    		 8.1%

    Short Ratio (days to cover)

    n/a
    		 6.31

    Valuation Ratios

    The PE ratio is -5.31 and the forward PE ratio is 35.3. Aldeyra Therapeutics's PEG ratio is -0.11.

    PE Ratio

    n/a
    		 -5.31

    Forward PE

    n/a
    		 35.3

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 4.18

    P/FCF Ratio

    n/a
    		 -6.87

    PEG Ratio

    n/a
    		 -0.11
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aldeyra Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.22.

    Current Ratio

    n/a
    		 5.48

    Quick Ratio

    n/a
    		 5.48

    Debt / Equity

    n/a
    		 0.22

    Debt / EBITDA

    n/a
    		 -0.25

    Debt / FCF

    n/a
    		 -0.35

    Interest Coverage

    n/a
    		 -31.21

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-6,205,666.67

    Employee Count

    n/a
    		 9

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 14.12% in the last 52 weeks. The beta is 0.68, so Aldeyra Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.68

    52-Week Price Change

    n/a
    		 14.12%

    50-Day Moving Average

    n/a
    		 2.54

    200-Day Moving Average

    n/a
    		 4.64

    Relative Strength Index (RSI)

    n/a
    		 76.84

    Average Volume (20 Days)

    n/a
    		 1,854,533

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -250K

    Operating Income

    n/a
    		 -60.12M

    Net Income

    n/a
    		 -55.85M

    EBITDA

    n/a
    		 -60.12M

    EBIT

    n/a
    		 -57.78M

    Earnings Per Share (EPS)

    n/a
    		 -0.94
    Full Income Statement

    Balance Sheet

    The company has 54.53M in cash and 15.3M in debt, giving a net cash position of 39.22M.

    Cash & Cash Equivalents

    n/a
    		 54.53M

    Total Debt

    n/a
    		 15.3M

    Net Cash

    n/a
    		 39.22M

    Retained Earnings

    n/a
    		 -450.11M

    Total Assets

    n/a
    		 93.2M

    Working Capital

    n/a
    		 77M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -43.21M and capital expenditures 0, giving a free cash flow of -43.21M.

    Operating Cash Flow

    n/a
    		 -43.21M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -43.21M

    FCF Per Share

    n/a
    		 -0.73
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ALDX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ALDX is $9.5, which is 144.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9.5

    Price Target Difference

    n/a
    		 144.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.2

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist